Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy

被引:0
|
作者
Sharma, Ishrya [1 ]
Hodges, Jacqueline [1 ]
Moonah, Shannon [1 ]
Shirley, Debbie-Ann [2 ]
机构
[1] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA
[2] Univ Virginia, Dept Pediat, Div Pediat Infect Dis, Charlottesville, VA USA
关键词
bacteremia; ertapenem; S; lugdunensis; ENDOCARDITIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that can cause serious infection similar to Staphylococcus aureus. Limited therapeutic options are available for patients with staphylococcal bacteremia who fail to respond to standard monotherapy, particularly when source control of infection is not feasible, driving the need for improved synergistic antibiotic combinations to enhance medical management. We present the case of a 58-year-old patient with persistent S. lugdunensis bacteremia for over 1 week despite appropriate therapy with nafcillin. Blood cultures were successfully sterilized following the addition of ertapenem salvage therapy, with rapid blood culture clearance within 2 days of initiation. To our knowledge, this is the first report of using ertapenem in combination with an antistaphylococcal penicillin to specifically clear persistent S. lugdunensis bacteremia. Similar success has been reported using this combination to treat methicillin-susceptible S. aureus infections; hence, our report provides further support for the benefit of this combination for staphylococcal infections.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Ulloa, Erlinda R.
    Singh, Kavindra, V
    Geriak, Matthew
    Haddad, Fadi
    Murray, Barbara E.
    Nizet, Victor
    Sakoulas, George
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (06) : 1413 - 1418
  • [2] Exploring combination treatment options for persistent methicillin-susceptible Staphylococcus aureus bacteremia
    Al Shaikhli, Hiba
    Akins, Ronda L.
    Stover, Kayla R.
    Barber, Katie E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, : 150 - 163
  • [3] Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Kufel, Wesley D.
    Zagoria, Zoey
    Blaine, Bruce E.
    Steele, Jeffrey M.
    Mahapatra, Rahul
    Paolino, Kristopher M.
    Thomas, Stephen J.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (04) : 360 - 365
  • [4] Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
    Monogue, Marguerite L.
    Ortwine, Jessica K.
    Wei, Wenjing
    Eljaaly, Khalid
    Bhavan, Kavita P.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 727 - 731
  • [5] Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia
    Wilsey, H. Andrew
    Pisani, Barbara
    O'Neill, Thomas J.
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (07) : 2127 - 2130
  • [6] Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate
    Hitchins, Margaret
    O'Mara, Keliana
    Edwards, Laura
    Bouchard, Jeannette
    PHARMACOTHERAPY, 2023, 43 (01): : 96 - 99
  • [7] Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan
    Shoji, Takayo
    Hirai, Yuji
    Osawa, Makiko
    Totsuka, Kyoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 175 - 180
  • [8] Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
    Marin L Schweizer
    Jon P Furuno
    Anthony D Harris
    J Kristie Johnson
    Michelle D Shardell
    Jessina C McGregor
    Kerri A Thom
    Sara E Cosgrove
    George Sakoulas
    Eli N Perencevich
    BMC Infectious Diseases, 11
  • [9] Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
    Schweizer, Marin L.
    Furuno, Jon P.
    Harris, Anthony D.
    Johnson, J. Kristie
    Shardell, Michelle D.
    McGregor, Jessina C.
    Thom, Kerri A.
    Cosgrove, Sara E.
    Sakoulas, George
    Perencevich, Eli N.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [10] Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis
    Gilbertie, Jessica
    Ulloa, Erlinda R.
    Daiker, Jennifer C.
    Nguyen, Khanh
    Smelter, Dan
    Rose, Warren
    Geriak, Matthew
    Schnabel, Lauren, V
    Nizet, Victor
    Sakoulas, George
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05):